Myriad Genetics, Inc.
MYGN
$3.05
-$0.15-4.69%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 115.20M | 124.40M | 149.60M | 145.40M | 74.40M |
| Total Receivables | 109.50M | 123.80M | 115.30M | 118.00M | 137.00M |
| Inventory | 30.60M | 27.90M | 30.60M | 31.60M | 28.70M |
| Prepaid Expenses | 33.70M | 36.70M | 35.40M | 49.80M | 44.20M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 1.70M | -- | -- |
| Total Current Assets | 289.00M | 312.80M | 332.60M | 344.80M | 284.30M |
|
|
|||||
| Total Current Assets | 289.00M | 312.80M | 332.60M | 344.80M | 284.30M |
| Net Property, Plant & Equipment | 158.90M | 162.50M | 163.40M | 162.00M | 164.20M |
| Long-term Investments | 47.10M | 47.10M | 51.60M | 51.60M | 51.60M |
| Goodwill | 47.10M | 47.10M | 51.60M | 51.60M | 51.60M |
| Total Other Intangibles | 139.00M | 145.70M | 153.40M | 163.10M | 170.10M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.90M | 5.60M | 5.60M | 6.60M | 7.10M |
| Total Assets | 638.90M | 673.70M | 706.60M | 728.10M | 677.30M |
|
|
|||||
| Total Accounts Payable | 30.40M | 32.60M | 30.00M | 31.80M | 30.90M |
| Total Accrued Expenses | 64.70M | 64.60M | 71.30M | 77.20M | 70.00M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.30M | 7.10M | 6.90M | 7.90M | 68.40M |
| Total Finance Division Other Current Liabilities | 28.30M | 25.90M | 25.60M | 31.10M | 30.60M |
| Total Other Current Liabilities | 28.30M | 25.90M | 25.60M | 31.10M | 30.60M |
| Total Current Liabilities | 130.70M | 130.20M | 133.80M | 148.00M | 199.90M |
|
|
|||||
| Total Current Liabilities | 130.70M | 130.20M | 133.80M | 148.00M | 199.90M |
| Long-Term Debt | 120.70M | 120.30M | 119.90M | 119.50M | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 82.50M | 84.10M | 83.00M | 84.90M | 86.20M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.10M | 1.70M | 1.90M | 2.90M | 3.10M |
| Total Liabilities | 335.00M | 336.30M | 338.60M | 355.30M | 289.20M |
|
|
|||||
| Common Stock & APIC | 1.50B | 1.49B | 1.49B | 1.49B | 1.48B |
| Retained Earnings | -1.20B | -1.16B | -1.12B | -1.11B | -1.09B |
| Treasury Stock & Other | 800.00K | 700.00K | 800.00K | -100.00K | -100.00K |
| Total Common Equity | 303.90M | 337.40M | 368.00M | 372.80M | 388.10M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 303.90M | 337.40M | 368.00M | 372.80M | 388.10M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 303.90M | 337.40M | 368.00M | 372.80M | 388.10M |
|
|
|||||